Arixtra and Aromasin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arixtra (fondaparinux sodium) and Aromasin (exemestane). Common drug interactions include diarrhoea among females.

The phase IV clinical study analyzes what interactions people have when they take Arixtra and Aromasin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Arixtra?

Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,830 Arixtra users. Check the latest studies of Arixtra.

What is Aromasin?

Aromasin has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 12,863 Aromasin users. Check the latest studies of Aromasin.

On Jul, 13, 2026

11 people who take Arixtra and Aromasin together, and have interactions are studied.

What are the common drug interactions of Arixtra and Aromasin, by gender? *:

female:

Diarrhoea
Performance status decreased
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Post procedural haemorrhage (post procedural bleeding)
Blood cholesterol increased
Blood triglycerides increased
Coma (state of unconsciousness lasting more than six hours)
Dyspnoea (difficult or laboured respiration)
Haematoma (collection of blood outside the blood vessels)

male:

n/a

What are the common drug interactions of Arixtra and Aromasin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Thrombocytopenia (decrease of platelets in blood)

50-59:

Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Post procedural haemorrhage (post procedural bleeding)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

60+:

Diarrhoea
Performance status decreased
Blood triglycerides increased
Coma (state of unconsciousness lasting more than six hours)
Haematoma (collection of blood outside the blood vessels)
High density lipoprotein decreased
Intraventricular haemorrhage (intraventricular bleeding)
Joint swelling
Nerve compression
Paralysis

What are the existing conditions these people have? *

Thrombosis (formation of a blood clot inside a blood vessel): 5 people, 45.45%
High Blood Pressure: 5 people, 45.45%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 36.36%
Skin Toxicity (skin damage due to toxin/poison): 2 people, 18.18%
Breast Cancer Metastatic: 2 people, 18.18%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Arixtra and Aromasin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously